13D/13G Filings - BIOCEPT INC (BIOCQ)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-06-02
4:26 pm
Purchase
2023-05-26 13G Biocept, Inc.
BIOCQ
Lind Global Fund II LP 147,294
9.900%
147,294increase
(New Position)
Filing
History
2021-01-05
10:50 am
Purchase
2020-12-31 13G Biocept, Inc.
BIOC
SABBY MANAGEMENT LLC 6,439
11.000%
6,439increase
(New Position)
Filing
History